John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

Infoblox Inc (BLOX) Pops on $1.6B Vista Equity Buyout

By John Kilhefner, Senior Managing Editor, Lango Franchise

Inloblox Inc (NYSE:BLOX) is returning to the private market in a deal by Vista Equity Partners that values BLOX stock at $1.6 billion.

3 Dependable Dividend Stocks to Buy for Shaky Times

By John Kilhefner, Senior Managing Editor, Lango Franchise

These three dependable dividend stocks boast strong underlying businesses and relentless dividend growth. They'll survive a rate hike easily -- if the Fed even delivers one.

VimpelCom Ltd (ADR) (VIP) Forfeits Gains on Secondary Offering

By John Kilhefner, Senior Managing Editor, Lango Franchise

VIP stock is being taken to the woodshed on intense volume after pricing a secondary offering of VimpelCom shares.

Novavax, Inc. (NVAX) Loses Almost Everything on Resolve Failure

By John Kilhefner, Senior Managing Editor, Lango Franchise

Novavax, Inc. (NASDAQ:NVAX) dropped like a stone amid disappointing trial data of its RSV vaccine. Can it bounce back?

Synergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch

By John Kilhefner, Senior Managing Editor, Lango Franchise

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) is continuing its run after Citigroup fueled speculation of an SGYP stock buyout.

Citigroup: Macy’s Inc (M) Could Have 27% Upside

By John Kilhefner, Senior Managing Editor, Lango Franchise

Recent Macy's Inc (NYSE:M) decisions have prompted Citigroup to upgrade M stock to "buy," as the holiday season sets Macy's up for success.

Allergan plc Ordinary Shares (AGN) Up on $639M Buyout of Vitae Pharmaceuticals Inc (VTAE)

By John Kilhefner, Senior Managing Editor, Lango Franchise

Allergan plc Ordinary Shares (NYSE:AGN) is buying Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) to ramp up its dermatology treatment offerings.

Intersil Corp (ISIL) Pops on Renesas Electronics Corp (RNECY) Buyout

By John Kilhefner, Senior Managing Editor, Lango Franchise

Intersil Corp is up nearly 10% after Renesas Electronics agreed to buy ISIL stock, which should boost RNECY's auto business.

Chesapeake Energy Corporation (CHK) Still Has Nearly 40% Upside

By John Kilhefner, Senior Managing Editor, Lango Franchise

Even after its gains last week, Chesapeake Energy Corporation (CHK) stock is continuing its run on renewed analyst bullishness.

GoPro Inc (GPRO) Bounces Back as Sept. 19 Event Nears

By John Kilhefner, Senior Managing Editor, Lango Franchise

GoPro (GPRO) is finally bouncing back, with GoPro stock getting a bid higher as the unveiling of its Karma drone and Hero 5 draw nearer.

Load More